Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Services (HCSG) Depreciation & Amortization (CF) (2016 - 2025)

Healthcare Services (HCSG) has disclosed Depreciation & Amortization (CF) for 17 consecutive years, with $3.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 7.44% to $3.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $16.8 million, a 15.04% increase, with the full-year FY2025 number at $16.8 million, up 15.04% from a year prior.
  • Depreciation & Amortization (CF) was $3.9 million for Q4 2025 at Healthcare Services, down from $4.0 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $5.0 million in Q2 2025 to a low of $3.2 million in Q3 2023.
  • A 5-year average of $3.8 million and a median of $3.7 million in 2021 define the central range for Depreciation & Amortization (CF).
  • Peak YoY movement for Depreciation & Amortization (CF): dropped 14.36% in 2023, then surged 35.93% in 2025.
  • Healthcare Services' Depreciation & Amortization (CF) stood at $3.7 million in 2021, then increased by 1.35% to $3.8 million in 2022, then rose by 0.61% to $3.8 million in 2023, then dropped by 4.68% to $3.6 million in 2024, then grew by 7.44% to $3.9 million in 2025.
  • Per Business Quant, the three most recent readings for HCSG's Depreciation & Amortization (CF) are $3.9 million (Q4 2025), $4.0 million (Q3 2025), and $5.0 million (Q2 2025).